Boston Trust Walden Corp has significantly invested in Cincinnati Financial Corporation, holding 755,847 shares valued at $118.9 million, making it their 13th largest position. Despite a slight reduction in shares, institutional ownership remains high at 65.24%. Cincinnati Financial recently reported strong quarterly earnings and declared a quarterly dividend of $0.94, with analysts maintaining a "Buy" rating and a price target of $183.25.

Boston Trust Walden Corp reduced its stake in Deere & Company by 4.6% in the first quarter, now holding 155,376 shares valued at approximately $87.5 million. This adjustment comes as Deere reported strong quarterly earnings, surpassing analyst expectations with $6.55 EPS and $13.37 billion in revenue, alongside declaring a quarterly dividend of $1.62 per share. Analysts maintain a "Moderate Buy" consensus rating for Deere, with an average price target of $642.23.

Boston Trust Walden Corp significantly reduced its stake in Ross Stores (NASDAQ:ROST) by 12.6% in the first quarter, selling 69,373 shares and retaining 481,674 shares valued at $104.3 million. Despite this, Ross Stores exceeded quarterly earnings expectations, reporting $2.02 EPS on $6.01 billion in revenue, and analysts maintain a "Moderate Buy" rating with an average target price of $233.18. The company also announced a quarterly dividend of $0.445 per share and provided positive FY2026 guidance.

Boston Trust Walden Corp reduced its stake in Procter & Gamble by 2.4% in the first quarter, selling 10,083 shares, while the company reported strong Q1 EPS, increased its dividend, and maintained a consensus "Moderate Buy" rating from analysts. The article also highlights mixed sentiment from analysts regarding PG's valuation and limited upside despite its strong dividend history.

Boston Trust Walden Corp increased its stake in Snap-On Incorporated by 3.8% in the first quarter, accumulating 226,007 shares valued at $82.1 million. This increase comes despite recent insider share sales by Snap-On executives totaling $14.0 million over 90 days. Snap-On also reported mixed Q1 earnings, approved a $500 million share buyback, and declared a quarterly dividend of $2.44 per share.

Boston Trust Walden Corp reduced its stake in IDEX Corporation by 2.2% in Q1 2026, selling 9,989 shares and retaining 452,714 shares valued at $85.8 million. IDEX reported strong Q1 results, exceeding EPS and revenue estimates, and announced a quarterly dividend of $0.73 per share. Analyst sentiment remains positive, with a "Moderate Buy" consensus and an average price target of $241.11, despite some insider selling.

Boston Trust Walden Corp reduced its stake in Union Pacific Corporation by 3.8% in Q1 2026, selling 12,354 shares and now holding 309,931 shares valued at $75.2 million. Despite this sale, Union Pacific reported strong quarterly results, exceeding analyst expectations with EPS of $2.93 and revenue of $6.22 billion, supported by significant institutional ownership and a "Moderate Buy" analyst consensus. The company also declared a quarterly dividend of $1.38 per share, yielding 2.0%.

West Pharmaceutical Services (WST) has experienced a 10-day winning streak, with its stock climbing 13% and its market cap increasing by $3.0 billion. Despite this strong performance, the stock is considered "Relatively Expensive" due to its "Very High valuation," suggesting that while operating performance is strong, the current price may not be an immediate buying opportunity. The article also provides a comparison of WST stock returns against the S&P 500 and highlights the Trefis High Quality Portfolio for outperforming benchmarks.

Boston Trust Walden Corp significantly increased its stake in NetApp, Inc. (NASDAQ:NTAP) by acquiring an additional 142,073 shares, bringing its total holdings to 631,452 shares valued at approximately $64.65 million. Other institutional investors also adjusted their positions in NetApp, with some making significant new acquisitions. The article also provides details on recent analyst ratings, insider transactions, and NetApp's financial performance, including its latest earnings report and dividend announcement.

Bronte Capital Management Pty Ltd. recently acquired 185,677 shares of The Walt Disney Company, amounting to approximately $17.9 million, making Disney its 12th largest holding. Institutional ownership in Disney remains robust at 65.71%, with several other major investors increasing their stakes. Analysts maintain a "Moderate Buy" consensus rating for Disney, with an average price target of $133.33, despite some recent minor target adjustments.